AI Verdict
ENS has stronger fundamentals based on our AI analysis.
ENSCW vs ENS Fundamental Comparison
| Metric | ENSCW | ENS |
|---|---|---|
| Revenue | $3.2M | $2.8B |
| Net Income | $-7.4M | $216.3M |
| Net Margin | -232.6% | 7.8% |
| ROE | -615.6% | 11.4% |
| ROA | -233.0% | 5.3% |
| Current Ratio | 1.27x | 2.75x |
| Debt/Equity | 0.00x | 0.61x |
| EPS | $-3.42 | $5.65 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ENSCW vs ENS: Frequently Asked Questions
Is ENSCW or ENS a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), ENS has stronger fundamentals. ENSCW is rated STRONG SELL (95% confidence) while ENS is rated BUY (75% confidence). This is not investment advice.
How does ENSCW compare to ENS fundamentally?
Ensysce Biosciences, Inc. has ROE of -615.6% vs EnerSys's 11.4%. Net margins are -232.6% vs 7.8% respectively.
Which stock pays higher dividends, ENSCW or ENS?
ENSCW has a dividend yield of N/A or no dividend while ENS has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ENSCW or ENS for long term?
For long-term investing, consider that ENSCW has STRONG SELL rating with 95% confidence, while ENS has BUY rating with 75% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ENSCW vs ENS?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ENSCW vs ENS, the AI consensus favors ENS based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.